Mr. Pratap Sandhu reports

THE PRECISION PEPTIDE COMPANY (BPC) EXPANDS ON EXCLUSIVE 50/50 REVENUE SHARE PEPTIDE PARTNERSHIP WITH MMA.INC (MMA)

The Precision Peptide Company Inc. has provided additional detail on its previously announced exclusive strategic marketing agreement with Mixed Martial Arts Group Ltd., and has outlined the strategic significance of the partnership for the company's commercialization road map.

A differentiated channel into the global combat sports community

Under the agreement, Precision has secured exclusive marketing rights across MMA Inc.'s digitally connected combat sports ecosystem, which the company believes represents a highly engaged, performance-driven and recovery-focused consumer demographic.

As at September, 2025, MMA Inc.'s platform includes over five million social media followers, approximately 530,000 user profiles, more than 75,000 active students, over 18,000 published gym profiles and more than 800 verified gym partners across 16 countries. Its platform assets span TrainAlta (a business-to-consumer training and participation platform), BJJLink (a gym management software-as-a-service platform), Hype and MixedMartialArts.com, all connected by a single sign on user infrastructure.

The partnership is strategically aligned with MMA Inc.'s rapidly expanding combat sports participation ecosystem. Brazilian jiu-jitsu, mixed martial arts, wrestling, boxing and related disciplines place significant physical demands on participants, creating natural demand for advanced recovery, resilience and performance optimization solutions.

MMA Inc.'s leadership and advisory roster

MMA Inc.'s board and strategic advisory roster bring substantial cultural and commercial weight to the partnership. As publicly disclosed by MMA Inc., members include:

• John Kavanagh, co-founder of MMA Inc., founder of SBG Ireland, World MMA coach of the year 2012 and long-time head coach to Conor McGregor, widely regarded as a leading martial arts coach;
• Conor McGregor, former UFC champion and a globally recognized figure in combat sports, who serves as a strategic adviser to MMA Inc. and, as announced this week, will headline UFC 329 against Max Holloway on July 11, 2026, in his first UFC appearance in five years;
• Donald Trump Jr., strategic adviser to MMA Inc., director of Trump Media and Technology Group, operator of Truth Social, and co-founder of World Liberty Financial;
• Laura Sanko, UFC commentator, former professional fighter and Brazilian jiu-jitsu black belt, who became the first female colour commentator in UFC history.

In addition, MMA Inc. has established an enterprise partnership with UFC Gym to roll out its warrior training program across 150 plus UFC Gym locations globally.

The company believes the combination of MMA Inc.'s leadership profile, ecosystem scale and commercial momentum provides Precision with a differentiated distribution channel available in the wellness and performance category today.

Capitalizing on the industry shift to compliant, U.S. manufactured peptides

The peptide category has expanded rapidly as consumer demand for advanced recovery, performance optimization, preventative health and longevity solutions has accelerated. At the same time, regulators are increasingly focused on manufacturing standards, product quality, labelling and commercialization practices. Precision believes this regulatory transition will accelerate a broader industry shift toward compliant, domestically manufactured and quality controlled providers.

Historically, large portions of the peptide market have operated through fragmented offshore manufacturing and grey market distribution channels with inconsistent quality standards. Precision's peptide products are manufactured in the United States and undergo third party testing protocols designed to emphasize purity, consistency and quality assurance, positioning the company as an operator during this industry transition.

Commercial structure

Under the agreement, net revenue derived from MMA sourced customer sales will be shared equally between the parties on a 50/50 basis during the first 12 months of the partnership, transitioning to a 75/25 split in favour of Precision for the rest of the term. Following any termination or expiration of the agreement, the parties will continue to share net revenue on sales to MMA referred customers for a 12-month tail period.

All peptide products sold under the agreement will be manufactured in the United States and will comply with all applicable U.S. regulatory requirements and standards, including those set by the U.S. Food and Drug Administration and any other applicable regulatory authority.

Pratap Sandhu, chief executive officer of Precision Peptide, commented: "This partnership is one of the most strategically aligned commercial channels we could have engineered for Precision. MMA Inc. has assembled the largest and most engaged digital ecosystem in global combat sports, supported by a leadership and advisory roster that includes Conor McGregor, Donald Trump Jr., John Kavanagh and Laura Sanko. Combined with Precision's uncompromising commitment to U.S. manufacturing and third party testing, we believe this partnership positions the company to become the peptide brand of choice for one of the world's most performance-driven consumer audiences."

Nick Langton, founder and chief executive officer of MMA Inc., also commented: "This partnership establishes an entirely new commercial vertical for MMA Inc. and positions the company at the intersection of several major long-term growth trends, including recovery therapeutics, longevity, preventative health and regulated peptide commercialization."

Further details regarding product launches, marketing campaigns and commercialization milestones are expected to be announced in subsequent updates.

About The Precision Peptide Company Inc.

Precision Peptide is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America.

We seek Safe Harbor.